World PulseNow
Newsletter

F.D.A.’s Approval of a Drug for Autism Upends Review Process

The New York Times•Tuesday, September 23, 2025 at 11:09:46 PM
PositiveHealth
F.D.A.’s Approval of a Drug for Autism Upends Review Process
The recent approval by the F.D.A. to expand the use of an existing drug for autism treatment is a significant development in the healthcare landscape. This decision has sparked a rush among consumers to purchase over-the-counter supplements containing similar ingredients, highlighting a growing interest in alternative treatments. Dr. Marty Makary, the F.D.A. commissioner, emphasized the importance of this move during a briefing led by President Trump, who also committed to investigating the underlying causes of autism. This approval not only offers new hope for individuals with autism but also reflects a shift in how treatments are approached.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
Dow Jones – Healthan hour ago
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
NegativeHealth
A notable number of doctors and policymakers are expressing concerns about the federal health guidance led by Robert F. Kennedy Jr., prompting them to establish an alternative public-health framework. This shift is significant as it reflects a growing distrust in established health protocols, which could lead to fragmented healthcare practices and varying standards of care across the country.
Read full article
via Dow Jones – Health
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
Dow Jones – Healthan hour ago
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
NegativeHealth
A notable number of doctors and policymakers are expressing concerns about the federal health guidance led by Robert F. Kennedy Jr., prompting them to establish an alternative public-health framework. This shift is significant as it reflects a growing distrust in established health protocols, which could lead to fragmented healthcare practices and varying standards of care across the country.
Read full article
via Dow Jones – Health
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
Dow Jones – Healthan hour ago
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
NegativeHealth
A notable number of doctors and policymakers are expressing concerns about the federal health guidance led by Robert F. Kennedy Jr., prompting them to establish an alternative public-health framework. This shift is significant as it reflects a growing distrust in established health protocols, which could lead to fragmented healthcare practices and varying standards of care across the country.
Read full article
via Dow Jones – Health
When it comes to Tylenol, what are parents to do?
NPR6 hours ago
When it comes to Tylenol, what are parents to do?
NeutralHealth
The debate surrounding Tylenol and its potential link to autism continues, with President Trump's assertions adding to the confusion. Parents are left navigating this complex issue, as the scientific evidence remains inconclusive. It's crucial for families to stay informed and make decisions based on the best available information regarding acetaminophen use.
Read full article
via NPR
When it comes to Tylenol, what are parents to do?
NPR6 hours ago
When it comes to Tylenol, what are parents to do?
NeutralHealth
The debate surrounding Tylenol and its potential link to autism continues, with President Trump's assertions adding to the confusion. Parents are left navigating this complex issue, as the scientific evidence remains inconclusive. It's crucial for families to stay informed and make decisions based on the best available information regarding acetaminophen use.
Read full article
via NPR
When it comes to Tylenol, what are parents to do?
NPR6 hours ago
When it comes to Tylenol, what are parents to do?
NeutralHealth
The debate surrounding Tylenol and its potential link to autism continues, with President Trump's assertions adding to the confusion. Parents are left navigating this complex issue, as the scientific evidence remains inconclusive. It's crucial for families to stay informed and make decisions based on the best available information regarding acetaminophen use.
Read full article
via NPR
World health officials reject Trump's claims that Tylenol is linked to autism
NPR8 hours ago
World health officials reject Trump's claims that Tylenol is linked to autism
NegativeHealth
World health officials have firmly rejected President Trump's claims that Tylenol could be linked to autism, particularly for pregnant women. This is significant because it highlights the importance of relying on scientific evidence over unverified assertions, especially when it comes to the health of expectant mothers and their babies. The World Health Organization reassures that Tylenol is safe to use during pregnancy, emphasizing the need for accurate information in public health discussions.
Read full article
via NPR
World health officials reject Trump's claims that Tylenol is linked to autism
NPR8 hours ago
World health officials reject Trump's claims that Tylenol is linked to autism
NegativeHealth
World health officials have firmly rejected President Trump's claims that Tylenol could be linked to autism, particularly for pregnant women. This is significant because it highlights the importance of relying on scientific evidence over unverified assertions, especially when it comes to the health of expectant mothers and their babies. The World Health Organization reassures that Tylenol is safe to use during pregnancy, emphasizing the need for accurate information in public health discussions.
Read full article
via NPR
World health officials reject Trump's claims that Tylenol is linked to autism
NPR8 hours ago
World health officials reject Trump's claims that Tylenol is linked to autism
NegativeHealth
World health officials have firmly rejected President Trump's claims that Tylenol could be linked to autism, particularly for pregnant women. This is significant because it highlights the importance of relying on scientific evidence over unverified assertions, especially when it comes to the health of expectant mothers and their babies. The World Health Organization reassures that Tylenol is safe to use during pregnancy, emphasizing the need for accurate information in public health discussions.
Read full article
via NPR
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
The New York Times10 hours ago
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
NegativeHealth
Kenvue, the company behind Tylenol and a recent spinoff from Johnson & Johnson, is facing a significant public relations crisis as President Trump and others raise concerns about unproven links between the pain reliever and autism. This situation is critical not only for Kenvue's reputation but also for consumer trust in its products, especially as it recently made its debut on the New York Stock Exchange. How Kenvue navigates this challenge could impact its future and the broader pharmaceutical industry.
Read full article
via The New York Times
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
The New York Times10 hours ago
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
NegativeHealth
Kenvue, the company behind Tylenol and a recent spinoff from Johnson & Johnson, is facing a significant public relations crisis as President Trump and others raise concerns about unproven links between the pain reliever and autism. This situation is critical not only for Kenvue's reputation but also for consumer trust in its products, especially as it recently made its debut on the New York Stock Exchange. How Kenvue navigates this challenge could impact its future and the broader pharmaceutical industry.
Read full article
via The New York Times
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
The New York Times10 hours ago
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
NegativeHealth
Kenvue, the company behind Tylenol and a recent spinoff from Johnson & Johnson, is facing a significant public relations crisis as President Trump and others raise concerns about unproven links between the pain reliever and autism. This situation is critical not only for Kenvue's reputation but also for consumer trust in its products, especially as it recently made its debut on the New York Stock Exchange. How Kenvue navigates this challenge could impact its future and the broader pharmaceutical industry.
Read full article
via The New York Times
Latest from Health
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
Dow Jones – Healthan hour ago
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe
NegativeHealth
A notable number of doctors and policymakers are expressing concerns about the federal health guidance led by Robert F. Kennedy Jr., prompting them to establish an alternative public-health framework. This shift is significant as it reflects a growing distrust in established health protocols, which could lead to fragmented healthcare practices and varying standards of care across the country.
Read full article
via Dow Jones – Health
NHS trust repays £5m over maternity failings
BBC News2 hours ago
NHS trust repays £5m over maternity failings
NegativeHealth
Leeds NHS Trust has repaid £5 million due to claims that their maternity services did not meet safe care standards. This situation highlights serious concerns about the quality of healthcare provided, particularly in maternity services, which are crucial for the safety of mothers and newborns. The repayment reflects accountability and raises questions about how such failings occurred, emphasizing the need for improvements in healthcare practices.
Read full article
via BBC News
After Trump's claims about acetaminophen, doctors try to reassure pregnant patients
NBC News2 hours ago
After Trump's claims about acetaminophen, doctors try to reassure pregnant patients
NeutralHealth
Following President Donald Trump's assertion that acetaminophen use during pregnancy may increase autism risk, medical professionals are reassuring expectant mothers that their recommendations remain unchanged. This is significant as it highlights the importance of clear communication in healthcare, especially regarding medications during pregnancy, ensuring that patients receive consistent and evidence-based guidance.
Read full article
via NBC News
Is leucovorin an effective treatment for autism? Here's what research shows
NBC News3 hours ago
Is leucovorin an effective treatment for autism? Here's what research shows
NeutralHealth
Recent discussions have emerged around leucovorin, a medication praised by the Trump administration for its potential to alleviate certain autism symptoms. However, experts in the field are urging caution, emphasizing the need for more comprehensive studies before considering its widespread use in children and adults. This highlights the ongoing debate about treatment options for autism and the importance of thorough research in ensuring safety and efficacy.
Read full article
via NBC News
On Covid and Autism, Trump Strays From the Science
The New York Times3 hours ago
On Covid and Autism, Trump Strays From the Science
NegativeHealth
President Trump has once again strayed from scientific consensus, this time warning pregnant women about an unproven link between acetaminophen and autism. This kind of misinformation can have serious implications for public health, especially during a pandemic when accurate information is crucial. His previous controversial statements, like suggesting bleach as a treatment for COVID-19, raise concerns about the impact of his words on vulnerable populations.
Read full article
via The New York Times
F.D.A.’s Approval of a Drug for Autism Upends Review Process
The New York Times3 hours ago
F.D.A.’s Approval of a Drug for Autism Upends Review Process
PositiveHealth
The recent approval by the F.D.A. to expand the use of an existing drug for autism treatment is a significant development in the healthcare landscape. This decision has sparked a rush among consumers to purchase over-the-counter supplements containing similar ingredients, highlighting a growing interest in alternative treatments. Dr. Marty Makary, the F.D.A. commissioner, emphasized the importance of this move during a briefing led by President Trump, who also committed to investigating the underlying causes of autism. This approval not only offers new hope for individuals with autism but also reflects a shift in how treatments are approached.
Read full article
via The New York Times